Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.

Data 105

Data Clinical Trials Research and Development Indica 105

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 272

Chronic Pain Patients Therapy Data 272

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. ”

Chronic Pain 260

Chronic Pain Access Collective Medicine 260

Veriheal

APRIL 11, 2024

This data aligns with Americans’ rising acceptance of cannabis. Policies like telemedicine, curbside pickup, and cannabis delivery made marijuana products more accessible and affordable to countless Americans. million patients in 2022, a sharp increase from the 3.1 The study also analyzed peoples’ reasons for registering.

Patients 108

Patients Chronic Pain Marijuana Conditions 108

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 186

Clinical Trials Chronic Pain Data Treatment 186

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NORML

FEBRUARY 1, 2019

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.

Patients 233

Patients Chronic Pain Therapy Data 233

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And

Data 52

Data Treatment Patients Chronic Pain 52

PrestoDoctor

SEPTEMBER 6, 2023

Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Veriheal

DECEMBER 14, 2023

The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronic pain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52

Access CBD Research and Development Medicine 52

SpeedWeed

JULY 10, 2021

This legislation provides important updates to our state’s medical marijuana program to ensure that patients have improved access to medication.”. With an adequate supply, there are 125 medical cannabis dispensaries in Pennsylvania with product available as of June 30, according to data from the Pennsylvania Department of Health.

Access 52

Access Research and Development Programs Chronic Pain 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. For too long, America has relied too heavily on opioids for pain relief. A Better Alternative for Chronic Pain. The Opioid Problem.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Healer

MARCH 26, 2021

That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronic pain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Joint Blog

DECEMBER 12, 2019

The research was published in the journal PLOS One – the name of the study is Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. For the study researchers “included data from people in 2 prospective cohorts. Methods and findings. Conclusions.

Chronic Pain 49

Chronic Pain Patients Data Sleep 49

Cannabis Law Report

JANUARY 3, 2022

According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases. In comparison, about 450 patients were prescribed a total of less than 5 kg of cannabis for therapeutic purposes in 2018.

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Medical cannabis is a safer alternative to the conventional opiate solutions and other pain management treatments. About LYPHE GROUP.

Extraction 105

Extraction Vaping Medicine Patients 105

Medicinal Marijuana Association

FEBRUARY 10, 2024

Differentiate between fact and fiction by accessing trustworthy information. Implement research findings by consulting experts and translating data into practical actions. By analyzing these studies, you can gain insights into the effects of cannabis on various medical conditions, such as chronic pain, epilepsy, and anxiety.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

APRIL 12, 2019

I have successfully reduced 85% of my opioid use for chronic pain as the result of arthritis through several surgeries and medical cannabis. CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication. million medical cannabis patients in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

The Cannigma

JULY 6, 2022

If you’re dealing with a lack of sleep from an overactive mind, anxiety, or chronic pain, weed strains with sedating, anti-anxiety, and pain-relieving properties may be able to help you get the shut eye you deserve. Below are recommendations mostly based on extrapolated animal data and studies on essential oils from plants.

Sleep 117

Sleep Terpenes Strains Chronic Pain 117

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

SpeedWeed

MAY 19, 2021

A recently released Canadian study has found that authorizations to use medical cannabis for chronic pain patients correlated to a reduction in opioid use among those to whom they are prescribed. An analysis of the data found that medical cannabis authorization had mixed results on short-term opioid use. View original article.

Chronic Pain 52

Chronic Pain Consumption Patients Access 52

SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 percent of veterans had used cannabis within the past six months.

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Canna Care Docs

DECEMBER 16, 2020

The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Cannigma

FEBRUARY 14, 2021

Despite the traumatic brain injury, chronic pain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.

Wellness and Beauty 145

Wellness and Beauty Data Terpenes Patients 145

Cannabis Law Report

AUGUST 27, 2021

This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

OCTOBER 28, 2020

Recent polling data in both states indicate warm support, sometimes across party lines. In South Dakota, polling data conducted by Mason-Dixon Polling & Strategy finds that three out of four voters — or 74% of respondents — intend to vote ‘yes’ on Initiative Measure 26. 3 could give access to medicine to more than 3.8

Data 52

Data Chronic Pain Recreational Advocacy 52

Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. “By Step five: The OBX and Radicle Science validated product is sent to production.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52